Back to search

Article

Evaluation of Artificial Intelligence (AI)-based <i>in silico</i> tools for variant classification in clinically actionable NSCLC variants

2024-04-14

Abstract excerpt

<h4>Introduction/Background</h4> Genetic variants beyond FDA-approved drug targets are often identified in non-small cell lung cancer (NSCLC) patients. Although the performances of in silico tools in predicting variant pathogenicity have been analyzed in previous studies, they have not been analyzed for actionable targets of FDA-approved therapies for NSCLC. The aim of this study is to compare the performance of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0f7dc144-781c-52f6-b7c6-d85f93c5fa14
DOI
10.1101/2024.04.12.24305738
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of Artificial Intelligence (AI)-based <i>in silico</i> tools for variant classification in clinically actionable NSCLC variantsDOI 10.1101/2024.04.12.24305738
Select a neighboring publication to make it the new centre.